Search PubMed⌕ Search

Biomedical subjects

H Kaneto

Publications and source records attributed to H Kaneto.

At least 145 records · Page 8Linked to original sources

Specific inhibitors for prolyl endopeptidase and their anti-amnesic effect.

Several peptides and peptide derivatives were tested for their inhibitory effect on prolyl endopeptidase and possible properties as anti-amnesic agents. Among the compounds tested, Z-Gly-Pro-CH2Cl, Z-Val-prolinal, Boc-Pro-prolinal, Z-Pro-prolinal, aniracetam and pramiracetam inhibited the enzyme activities at Ki values in the order of nM to microM, and the effect of the prolinal-containing peptide derivatives was specific for prolyl endopeptidase. Z-Pro-prolinal was the most effective inhibitor in vitro (Ki = 5 nM) and in vivo (50 to 70% inhibition in various organs of rat at a dose of 1 mumol/animal i.p.). Regional differences were observed in the effect of inhibitors on the brain enzyme activities: most active in mesencephalon, followed by striatum, cerebellum, hippocampus, hypothalamus; and inactive in cerebral cortex and medulla oblongata. In the passive avoidance learning test using rats, pretreatment with Z-Pro-prolinal prevented the induction of amnesia by scopolamine at the dose of 1 mumol/animal, i.p. Z-Val-prolinal, Z-Pyr-prolinal and Z-Gly-Pro-CH2Cl were also effective in the retention test at 24 and 48 h after the training trial. The antiamnesic effect of these compounds was approximately parallel to the in vitro inhibitory activities on prolyl endopeptidase. These results suggest the possibility that the inhibitors exhibit their anti-amnesic effect through the regulation of the enzyme activity in the brain.

Amnesia↗

[Anti-amnesic effect of prolyl endopeptidase inhibitors in mice].

Based on the results of a previous report that prolyl endopeptidase (PPCE) inhibitors facilitated the acquisition of active avoidance response and retarded the extinction of the response, further studies were made on the effect of PPCE inhibitors on learning and the memory process. Using mice, tests were performed both in the light-dark discrimination Y-maze task and the lever-press task of the water reinforcement schedule, and mice were also tested in the acquisition and retention of one-trial "step-through" passive avoidance task. The effect of PPCE inhibitors were investigated both in control and electroconvulsive shock- or scopolamine-induced amnesic animals. Z-Pro-p, the most potent inhibitor among 5 compounds tested in this study, and arginine vasopressin (AVP) facilitated the learning process and retarded the extinction of the acquired response in all tests. Suc-Pro-p was also effective in the Y-maze and passive avoidance test. Thus, the effect of the test compounds were parallel with their in vitro activities as PPCE inhibitor. These results suggest that the anti-amnesic effect of PPCE inhibitors is partially attributable to their effect on the breakdown of the biologically active peptides which are involved in the memory process, such as AVP, in the brain.

Amnesia↗

Implication of endogenous opioid mechanism in the production of the antinociceptive effect induced by psychological stress in mice.

Psychological (PSY) stress using the communication box produced a short-lasting antinociceptive effect which was less potent than that induced by physical stress such as footshock (FS) and forced swimming (SW) in mice. Naloxone completely antagonized PSY-stress induced analgesia (SIA) when the analgesia was measured by the tail pinch (TP) method; however, the antagonist did not reverse the effect in the tail flick (TF) assay. On the other hand, FS-SIA was antagonized by naloxone in both methods, while naloxone failed to reverse SW-SIA in either TF or TP assessment. Daily exposure to psychological stress developed tolerance to the analgesia. One-way cross-tolerance between PSY-SIA and morphine and the naloxone antagonism of PSY-SIA by the tail pinch method lead to the suggestion that an endogenous opioid system may be involved in the underlying mechanism for its production. On the contrary, from the findings of cross-tolerance between SW- or FS-SIA and the lack of naloxone antagonism in the TF method, the involvement of a more complicated mechanism is suggested in PSY-SIA. In both tests, U-50488H, a selective kappa-agonist, produced profound analgesia; however, no appreciable antagonism of naloxone was found in the TF test, whereas the effect was completely blocked by naloxone in the TP test. From the similarity in naloxone antagonism of PSY-stress and U-50488H induced analgesia, the participation of a common mechanism which may be mediated by kappa-opioid receptors, is suggested in the production of PSY-SIA.

3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cycloh↗

[Experimental models for studying the avoidance response in mice and the anti-amnesic effect of prolyl endopeptidase inhibitors].

Prolyl endopeptidase (PPCE) plays an important role in the degradation of biologically active peptides such as vasopressin which facilitates the process of learning and memory. Here, the effect of synthetic PPCE inhibitors (Z-Pro-, Suc-Pro-, Suc-Pyr-, Suc-Sar- and Z-prolinal) on the acquisition and retention of avoidance response was studied. Using mice of the ddY strain, tests were performed both in repeated trials of an active avoidance task and in a newly contrived one-trial passive-active avoidance task. The applicability of both tests for the evaluation of the anti-amnesic effect of the drugs was confirmed by the effect of scopolamine and arginine vasopressin (AVP). The most potent inhibitor, Z-Pro-prolinal, facilitated the acquisition of active avoidance response and retarded the extinction of the response. Other inhibitors also facilitated the retention of the acquired response. In the one-trial passive-active avoidance test, the facilitating effect of the PPCE inhibitors on the acquisition was parallel to their activity as a PPCE inhibitor. Scopolamine-induced amnesia was also improved by the inhibitors. These results suggest that the anti-amnesic effect of PPCE inhibitors is partially attributed to their inhibitory effect on the breakdown of AVP in the brain.

Amino Acids↗

Pharmacological characterization of alcohol and barbital physical dependence in mice.

To confirm our previous finding that the underlying mechanism for the development of physical dependence on alcohol and barbital are fundamentally different from each other, further studies on the effect of drugs that modify neurotransmission on the alcohol and barbital withdrawal signs were carried out in alcohol and barbital dependent mice. Phentolamine, propranolol and methysergide exacerbated the alcohol withdrawal signs but suppressed the barbital withdrawal signs indicating the qualitative difference of the underlying mechanism. Some quantitative differences were also found in the effect of clonidine, prazosin, yohimbine, muscimol and bicuculline. On the other hand, metoprolol, atropine and scopolamine did not affect the withdrawal signs developed in the alcohol and barbital dependent animals at the dose employed in the present experiment. These results indicate that the withdrawal signs that appear in alcohol and barbital dependent animals are the manifestation of functional abnormalities of the nervous system, and alcohol and barbital dependence rely on different mechanisms for their production.

Animals↗

Reverse tolerance to the swimming time prolonging effect of d-amphetamine in mice.

Development and disappearance of reverse tolerance to the swimming time prolonging effect of d-amphetamine (AMP) was studied in mice in comparison with that to the ambulation accelerating effect. The swimming time prolonging effect was progressively enhanced by daily administration of 2 mg/kg AMP. The development of reverse tolerance to the effect was more rapid than that to the ambulation accelerating effect and reached its maximal level by 5-6 repetitions. Repetition at a daily interval was more effective than at the interval of 3-4 days, and administration at a weekly interval failed to develop the reverse tolerance. Restriction of swimming space or immobilization in a small box after administration of AMP blocked the development of reverse tolerance. Reverse tolerance to the swimming time prolonging effect disappeared faster than that to the ambulation accelerating effect, but the enhancement was well maintained after 30 days of withdrawal. Thus, many factors affect the development of reverse tolerance to the various effects of AMP; however, the swimming time prolonging effect is a simple, sensitive, and reproducible index for the study of this phenomenon.

Animals↗

Morphine analgesia without development of tolerance in reserpinized mice.

The relationship between the brain monoaminergic mechanism and morphine tolerance was examined in reserpinized mice. In parallel with the reduction of brain monoamine content, the analgesic effect of morphine was reduced in reserpinized animals. At the peak of the reserpine effect, 24 hr after a single dose of 2.5 mg/kg reserpine, i.p., the analgesic effect of morphine was lowered to about 45% of that in naive animals; and 5 days after reserpine treatment, it recovered to about 60% of the control activity. In these animals, the lowered effect of morphine was maintained at the same range during 6 daily repetitions, and the development of tolerance was suppressed. When daily morphine injection was started from 10 days after reserpine treatment, at the time when the brain level of monoamines was still reduced to 60 to 80% of the control, tolerance developed as rapidly as in control animals. On the other hand, daily treatment with a small dose of reserpine, 0.1 mg/kg, neither affected the brain level of norepinephrine and dopamine nor modified morphine analgesia, but completely blocked the development of tolerance. These results may suggest that suppression of the development of tolerance to morphine analgesia is not attributed to the reduction of brain norepinephrine and dopamine by reserpine. Morphine analgesia without development of tolerance in reserpinized mice may indicate the dissociation of the analgesic effect from tolerance liability.

Animals↗

Important role of adrenergic function in the development of analgesic tolerance to morphine in mice.

The involvement of a catecholaminergic mechanism in the production of morphine analgesia and the development of tolerance to the effect has been suggested. Here, using various adrenergic blockers, the role of adrenergic function in the mechanism was examined. Phentolamine (alpha 1 + alpha 2-blocker, 10, 1 and 0.5 mg/kg), prazosin (alpha 1-blocker, 0.1 and 0.02 mg/kg), propranolol (beta 1 + beta 2-blocker, 10, 1 and 0.5 mg/kg), metoprolol (beta 1-blocker, 10 and 1 mg/kg) did not affect morphine analgesia, but dose-dependently suppressed the development of tolerance to morphine. Yohimbine (alpha 2-blocker, 5 and 1 mg/kg) dose-dependently antagonized morphine analgesia in naive animals and delayed the development of tolerance to morphine. Pindolol (beta 1 + beta 2-blocker but is devoid of membrane stabilizing activity) suppressed the development of tolerance to morphine analgesia; however, d-propranolol, which possesses membrane stabilizing activity but lacks beta-blocking activity, could not prevent the development of tolerance. Thus, the suppressive effect of propranolol on the development of tolerance is not due to membrane stabilizing properties. Not only the non-selective adrenergic blockers, phentolamine and propranolol, but also the selective blockers of each receptor subtype, prazosin and metoprolol, suppressed the development of tolerance. This fact may suggest the importance of the equilibrated state of adrenergic functions in the mechanism for the development of tolerance to morphine.

Adrenergic alpha-Antagonists↗

[A study on hemorrhage during and after operation of TURP (transurethral prostatic resection)--effect of morphine or buprenorphine for suppression of postoperative hemorrhage by epidural infusion].

The majority of hemorrhages occurring during open prostatectomy are induced during the steps for removal of adenoma. However, the hemorrhage during transurethral prostatic resection (TURP) usually takes place at its initial stage, and approx. 50% of the amount of the hemorrhage during the operation occurred within 30 minutes after initiating the operation. When the resection of the adenoma advanced near the surgical capsule, the amount of hemorrhage decreased sharply. This was interpreted to indicate that many of the blood vessels are cut at the initial stage of the operation and that the steps for resection are processed at that stage without special attempt to stop the hemorrhage. We have discussed some aspects for improvement of the methodology for the operation of this kind. The postoperative progress of hemorrhage revealed that the operative cases can be classified into three groups; one was the group with smooth hemostasis since immediately after the operation (Type I and II) and the others were the group with satisfactory hemostasis during the operation and yet with resumption of substantial hematuria (Type III and IV) and the group with continued hemorrhage of substantial amount since immediately after the operation (Type V). It was demonstrated that those showing hematuria of more than 2% at 2-4 hours after the operation and 0.5-1.9% at 6-8 hours after the operation can be rated as falling under the latter two groups and that the check at an early stage and early counter-treatment would induce favorable postoperative progress.(ABSTRACT TRUNCATED AT 250 WORDS)

Buprenorphine↗

Differentiation of alcohol and barbital physical dependence.

In order to elucidate the fundamental differences between alcohol and barbital physical dependence, comparative studies were made on the effect of various drugs on the withdrawal signs developed in alcohol and barbital dependent mice. Ethanol, barbital and diazepam, drugs of alcohol-barbiturate type dependence liability, and ethosuximide, an anticonvulsant, suppressed both withdrawal signs in a dose dependent manner. The effects of these drugs were different from each other only quantitatively and no special difference was observed between the effects on alcohol and barbital withdrawal signs. On the other hand, the effects of phenytoin, an anticonvulsant, and pentylenetetrazol, a convulsant, were only evident in alcohol dependent animals. Phenytoin elicited body tremor and markedly exacerbated the alcohol withdrawal signs, but slightly suppressed the barbital withdrawal signs. Dose-response curves for the convulsive effect of pentylenetetrazol obtained at the peak of the withdrawal signs shifted greatly to the left in alcohol withdrawn animals but less in barbital withdrawn animals. These discrepancies between the effects on alcohol and barbital withdrawal signs may suggest a difference in the underlying mechanisms for the production of alcohol and barbital physical dependence.

Animals↗

Evidence for the dissociation of morphine analgesia, tolerance and dependence.

A single large dose of morphine produced profound analgesia accompanied by the development of tolerance and physical dependence. The tolerance developed acutely within 24 h and was further intensified, reaching a peak on the 5th day, then gradually disappeared. Partial or complete masking of morphine analgesia by naloxone inhibited the development of the acute, but could not prevent the development of the delayed, tolerance. These results suggest there are two kinds of tolerance and that the analgesic effect is separate from tolerance. Similarly, treatment with morphine produced physical dependence which was precipitated by naloxone. Unlike tolerance, dependence did not develop when morphine analgesia was completely masked by naloxone. The findings provide for the dissociation or morphine analgesia, tolerance and dependence.

Analgesics↗

Involvement of different receptor subtypes for the production of in vitro and in vivo effects in a series of synthetic enkephalin analogues.

Enkephalin analogues of tyrosyl group on the N-terminal and Phe-ol or phenylethylamine (PHA) group on the C-terminal which are connected with different chain length were tested for their activities in vitro and in vivo. The inhibitory effect of the synthetic peptides on the electrically evoked contractions of isolated longitudinal muscle strips of guinea pig ileum were weaker than that of morphine or Leu-enkephalin and tended to decrease by increasing the number of methylene group,-(CH2)n-, n = 1-5, between N- and C-terminal. Compounds with PHA group on the C-terminal, n = 4 and 5, showed the least activity. The effect of peptides with short chains of methylene groups, n = 1 or 2, and Phe-ol on the C-terminal were antagonized by naloxone but others were insensitive to naloxone. Differing from in vitro activity, compounds with PHA on the C-terminal with a chain of 4 methylene groups produced short lasting analgesia after i.c.v. injection as well as the compounds with Phe-ol on the C-terminal and 1 or 2 methylene groups. The analgesic effect of these compounds were completely antagonized by naloxone. At a high i.c.v. dose, all the synthetic peptides, except the one with PHA on the C-terminal with a chain of 4 methylene group, produced convulsions and/or ipsilateral rotation to the injection side. These behavioral effects were not antagonized by naloxone. Thus, minor alterations in the chemical structure of enkephalin analogues resulted in the changes of their receptor selectivity and potencies in vitro and in vivo.

Analgesia↗

Comparative studies on morphine- and stress-induced analgesia and the development of tolerance to the effects: implication of protein synthesis mechanism in the process.

Comparative studies were made on morphine- and stress-induced analgesia (SIA) and also on the development of tolerance to the effects. Cycloheximide (CYH), a potent protein synthesis inhibitor, did not affect the analgesic effect of morphine, but effectively suppressed the development of tolerance. CYH, however, potentiated both foot shock (FS) and immobilized-water immersion (IW) SIAs and inhibited the development of tolerance to FS-SIA. Incorporation of 3H-leucine into the TCA-insoluble fraction of mouse brain regions was inhibited by morphine, and the inhibition was reversed by the pretreatment with CYH. The inhibitory effect of morphine was lost in morphine tolerant animals. At the peak of SIA, incorporation of 3H-leucine was not changed in FS-SIA, but significantly inhibited in IW-SIA, and these effects were not modified by the pretreatment with CYH. The reduced incorporation of 3H-leucine in IW-SIA tolerant animals was partially reversed by CYH. Thus, the protein synthesis mechanism is greatly influenced by morphine or stresses, but the direct evidence for the implication of the mechanism in the process of producing analgesia and tolerance formation could not be demonstrated. However, differences in the underlying mechanisms were apparent between morphine and SIAs and also between FS- and IW-SIA.

Animals↗

Diversity of underlying mechanisms in the production of analgesic and pentobarbital-hypnosis prolonging effects of various analgesic drugs and stresses.

Stressful stimuli, electric footshock (FS), immobilized-water immersion (IW), and cold-water swimming (CWS), produced analgesia and prolonged the pentobarbital hypnosis as well as morphine and clonidine. Naloxone completely antagonized the analgesic effects of morphine and FS and partially that of IW; however, that of clonidine and CWS were not reversed by naloxone. Naloxone eliminated the hypnosis prolonging effect of morphine and FS, but failed to reverse the effect of clonidine, IW and CWS. Differences in the analgesic and hypnosis prolonging effects and also the respective naloxone sensitivity of each drug and stress suggest the diversity of the underlying mechanisms.

Analgesics↗

Single dose tolerance to the analgesic effect of clonidine and cross-tolerance between morphine and clonidine.

A single dose of clonidine developed tolerance to its analgesic effect. The tolerance reached its peak acutely on the 2nd day and lasted more than 5 days. Neither the analgesic effect nor the development of tolerance was modified by the pretreatment with naloxone. On the 2nd day, clonidine tolerant animals were also tolerant to morphine, but morphine tolerant animals, after a single dose of morphine on the 1st day, were not tolerant to clonidine. On the 5th day, however, clonidine tolerant animals were tolerant to morphine, and vice versa. Thus, the interaction between morphine and clonidine was "one-way" on the 2nd day, and cross-tolerance was only demonstrated on the 5th day. With a treatment with clonidine plus naloxone on the 1st day, the development of cross-tolerance to morphine was completely suppressed on the 2nd day but not on the 5th day. These results confirmed our previous finding that acute and delayed tolerance are different in nature, and the development of tolerance to morphine and clonidine are partially underlaid with a common mechanism which is not mediated by opioid receptors.

Analgesics↗

The role of the catecholaminergic mechanism in foot shock (FS) stress- and immobilized-water immersion (IW) stress-induced analgesia in mice.

Involvement of the catecholaminergic mechanism in foot shock (FS)- and immobilized-water immersion (IW)-stress-induced analgesia (SIA) and in the development of tolerance to the effect were investigated in mice. With daily treatment with clonidine or daily exposure to stresses, tolerance developed rapidly to the analgesic effect. Clonidine-induced analgesia, which could not be antagonized by naloxone, was potentiated in the animals rendered tolerant to FS-stress, and it was attenuated in the animals tolerant to IW-SIA. On the other hand, animals tolerant to clonidine failed to show the attenuation of FS- and IW-SIA. The analgesic effect of clonidine and the development of tolerance to the effect were not influenced by reserpine. However, reserpine pretreatment completely suppressed the analgesic effect induced by FS- and IW-stresses on the 1st day; but with daily exposure to the stress, the analgesic effect gradually appeared and returned to the control level on the 5th day. These results indicate not only the differences between clonidine analgesia and SIAs but also those between each SIA. Thus, the central catecholaminergic mechanisms play an important role in these SIAs and also in the development of tolerance to the effect, although the degree of participation of these mechanisms seems to be somewhat different between FS- and IW-SIA, as indicated by the cross-tolerance between clonidine analgesia and each SIA.

Analgesia↗